Premium
Acute antibody‐mediated rejection in pediatric kidney transplants: A single center experience
Author(s) -
Twombley Katherine,
Thach Lonnie,
Ribeiro Annelise,
Joseph Catherine,
Seikaly Mouin
Publication year - 2013
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/petr.12129
Subject(s) - medicine , rituximab , single center , complication , pediatrics , kidney transplantation , incidence (geometry) , surgery , transplantation , lymphoma , physics , optics
Abstract aAMR is a potentially devastating complication of kidney transplantation. The incidence of aAMR in children, while thought to be rare, is not well defined, and there is a paucity of data on treatment regimens in children. We retrospectively reviewed the outcomes of our pediatric patients that were treated for aAMR between 2007 and 2009. Three adolescent Hispanic males were found to have aAMR. All three received deceased donor transplants, and all three verbalized non‐adherence. Treatment consisted of rituximab, solumedrol, PE, and IVIgG in one patient, and PE, IVIgG, and bortezomib in two patients. The only side effect of therapy noted was mild hypotension with rituximab that resolved after decreasing the infusion rate. There were no reported infections two yr after treatment, and all of the viral monitoring in these patients remained negative.